Literature DB >> 25171316

Reply: interactions and clarifying group-specific estimates by using stratification.

Kevin Molloy1, Tomas P Carroll, Craig P Hersh, Jessica A Lasky-Su, Noel G McElvaney.   

Abstract

Mesh：

Substances：

Year:  2014        PMID： 25171316      PMCID： PMC5955068          DOI： 10.1164/rccm.201406-1085LE

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN： 1073-449X            Impact factor:   21.405


× No keyword cloud information.
  4 in total

Review 1.  Prevalence of α1-antitrypsin deficiency alleles PI*S and PI*Z worldwide and effective screening for each of the five phenotypic classes PI*MS, PI*MZ, PI*SS, PI*SZ, and PI*ZZ: a comprehensive review.

Authors:  Frederick J de Serres; Ignacio Blanco
Journal:  Ther Adv Respir Dis       Date:  2012-08-29       Impact factor: 4.031

2.  Clarification of the risk of chronic obstructive pulmonary disease in α1-antitrypsin deficiency PiMZ heterozygotes.

Authors:  Kevin Molloy; Craig P Hersh; Valerie B Morris; Tomás P Carroll; Catherine A O'Connor; Jessica A Lasky-Su; Catherine M Greene; Shane J O'Neill; Edwin K Silverman; Noel G McElvaney
Journal:  Am J Respir Crit Care Med       Date:  2014-02-15       Impact factor: 21.405

Review 3.  Alpha1-antitrypsin deficiency. 1: epidemiology of alpha1-antitrypsin deficiency.

Authors:  M Luisetti; N Seersholm
Journal:  Thorax       Date:  2004-02       Impact factor: 9.139

4.  The prevalence of alpha-1 antitrypsin deficiency in Ireland.

Authors:  Tomás P Carroll; Catherine A O'Connor; Olwen Floyd; Joseph McPartlin; Dermot P Kelleher; Geraldine O'Brien; Borislav D Dimitrov; Valerie B Morris; Clifford C Taggart; Noel G McElvaney
Journal:  Respir Res       Date:  2011-07-13
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.